Daniel A. Simkowitz - 12 Mar 2026 Form 4 Insider Report for MORGAN STANLEY (MS)

Signature
/s/ Martin M. Cohen, Attorney-in-Fact
Issuer symbol
MS
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 16:19:41 UTC
Previous filing
20 Feb 2026
Next filing
17 Apr 2026

Quoteable Key Fact

"Daniel A. Simkowitz filed Form 4 for MORGAN STANLEY (MS) on 13 Mar 2026."

Quick Takeaways

  • This page summarizes Daniel A. Simkowitz's Form 4 filing for MORGAN STANLEY (MS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 13 Mar 2026, 16:19.

What Changed

  • Previous filing in this sequence was filed on 20 Feb 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SIMKOWITZ DANIEL A Co-President C/O MORGAN STANLEY, 1585 BROADWAY, NEW YORK /s/ Martin M. Cohen, Attorney-in-Fact 13 Mar 2026 0001680385

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MS Common Stock Award +32,865 +8.8% $0.000000* 406,667 12 Mar 2026 Direct F1
transaction MS Common Stock Tax liability -18,175 -4.5% $160.89* 388,492 12 Mar 2026 Direct F2
holding MS Common Stock 1,805 12 Mar 2026 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned based on the Company's achievement of pre-established relative return on tangible common equity performance criteria with respect to one-half of the target performance stock unit award ("PSU Award") granted on January 18, 2023.
F2 Shares withheld to satisfy taxes upon the conversion of the PSU Award described in footnote (1).